What is Michelle A. Hodges’ QuidelOrtho (QDEL) share ownership after the reported transactions?

Following the February 8, 2026 transactions, Michelle A. Hodges directly owned 41,605 shares of QuidelOrtho common stock. This balance reflects both the shares issued from restricted stock unit vesting and the shares withheld to cover associated tax obligations.

QuidelOrtho CLO has 3,198 RSUs vest, shares withheld for tax

QuidelOrtho Corp Chief Legal Officer reports equity award vesting and tax withholding.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

QuidelOrtho Corp Chief Legal Officer reports equity award vesting and tax withholding. On February 8, 2026, Michelle A. Hodges had 3,198 restricted stock units convert into an equal number of common shares at a stated price of $0, increasing her directly held stake.

In connection with this vesting, 1,148 common shares were disposed of at $29.10 per share to cover tax withholding obligations, rather than being an open-market sale. After these transactions, Hodges directly owned 41,605 shares of QuidelOrtho common stock.

Insider Trade Summary

3,198 shares exercised/converted

Exercise 3 txns

Insider Hodges Michelle A

Role Chief Legal Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	3,198	$0.00	$0.00
Grant/Award	Common Stock	3,198	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	1,148	$29.10	$33K

Holdings After Transaction: Restricted Stock Units — 3,198 contracts (Direct); Common Stock — 41,605 shares (Direct)

Footnotes (4)

F1. Reflects release of restricted stock units that were previously reported on a Form 4.
F2. Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
F3. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F4. 3,197 shares vested on February 8, 2025; 3,198 shares vested on February 8, 2026; and the remaining 3,198 shares will vest on February 8, 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did QuidelOrtho (QDEL) report for Michelle A. Hodges?

QuidelOrtho reported that Chief Legal Officer Michelle A. Hodges had 3,198 restricted stock units vest into common shares. The filing also shows related share withholding for taxes, reflecting routine equity compensation rather than discretionary share purchases or open-market sales.

How many QuidelOrtho (QDEL) RSUs vested for Michelle A. Hodges on February 8, 2026?

On February 8, 2026, 3,198 restricted stock units vested for Michelle A. Hodges. Each unit represents one share of QuidelOrtho common stock, so 3,198 new shares were issued to her as part of the company’s equity compensation program.

Why were 1,148 QuidelOrtho (QDEL) shares disposed of in this Form 4?

The 1,148 shares were withheld by QuidelOrtho to satisfy tax withholding obligations tied to the RSU vesting. This disposition reflects a tax-related withholding mechanism, not a discretionary open-market sale by Chief Legal Officer Michelle A. Hodges.

What role does Michelle A. Hodges hold at QuidelOrtho (QDEL)?

Michelle A. Hodges serves as Chief Legal Officer at QuidelOrtho. Her Form 4 filing details equity compensation activity, including restricted stock units converting into common shares and related tax withholding, which is typical for senior executive compensation packages.

How do QuidelOrtho (QDEL) restricted stock units reported here work?

Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock upon vesting. The filing notes past and future vesting dates, with installments vesting in 2025, 2026, and a remaining tranche scheduled to vest on February 8, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 02/10/2026 - 04:10 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hodges Michelle A

(Last)

(First)

(Middle)

9975 SUMMERS RIDGE ROAD

(Street)

SAN DIEGO

92121

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
QuidelOrtho Corp [ QDEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/08/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/08/2026		A		3,198⁽¹⁾	A	$0	42,753	D
Common Stock	02/08/2026		F		1,148⁽²⁾	D	$29.1	41,605	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽³⁾	02/08/2026		M			3,198	⁽⁴⁾	⁽⁴⁾	Common Stock	3,198	$0	3,198	D

Explanation of Responses:

1. Reflects release of restricted stock units that were previously reported on a Form 4.

2. Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.

3. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

4. 3,197 shares vested on February 8, 2025; 3,198 shares vested on February 8, 2026; and the remaining 3,198 shares will vest on February 8, 2027.

Remarks:

	/s/ Phillip S. Askim, attorney-in-fact for Michelle A. Hodges	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR